Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

INTRODUCTION: Antipsychotic medications are used to treat individuals with severe mental illness (SMI) but are associated with rapid weight gain and several physical and mental risk factors. Early, proactive weight management is necessary to preempt these risk factors. The aim of this research was to understand and explain how, why, for whom, and in what contexts non-pharmacological interventions can help to manage antipsychotic-induced weight gain. METHODS: A realist review was conducted to identify contextual factors and underlying mechanisms associated with effective, non-pharmacological weight management interventions for adults > 18-years old. Practitioners and lived experience stakeholders were integral. RESULTS: Seventy-four documents were used to construct a program theory and 12 testable context-mechanism-outcome configurations. People with SMI benefit from support when navigating interventions aimed at managing weight gain. From a practitioner perspective, a good therapeutic relationship is important in helping people with SMI navigate early diagnosis and treatment options and facilitate the exploriation of any pre-existing issues. Interventions that are flexible and tailored to the needs of individuals, ideally starting early in a person's recovery journey, are likely to yield better results. Additional sources of support include family, friends, and peers with lived experience who can help individuals transition to autonomous goal-setting. The review findings also emphasizes the significant effect of stigma/dual stigma on individuals with SMI and weight gain. CONCLUSIONS: Successful interventions are collaborative, flexible, and underpinned by early and comprehensive assessment with the use of appropriate behavior change approaches. The therapeutic relationship is key, with a destigmatizing approach required. A realist evaluation with primary data is currently underway.

Original publication

DOI

10.1111/obr.13962

Type

Journal article

Journal

Obes Rev

Publication Date

27/07/2025

Keywords

antipsychotics, cardiometabolic syndrome, lived experience, obesity, realist research, realist review, severe mental illness, weight gain